Showing results (711-720 of 730) with videos related to

Sort By:
Pageof 73
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 4, 1998
[Clinical evaluation of a reagent for detection of DNA of Mycobacterium tuberculosis complex using the ligase chain reaction (LCR) method]H Koga, S Kohno, K Tomono, et al.
Scandinavian Journal of Rheumatology|May 16, 2009
Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional studyK Fujikawa, A Kawakami, K Kaji, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|July 1, 1997
Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infectionsT Mori, H Ikemoto, M Matsumura, et al.
The Japanese Journal of Antibiotics|August 1, 1996
[Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase]H Koga, K Tomono, Y Hirakata, et al.
The Japanese Journal of Antibiotics|July 9, 1999
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]M Inoue, S Kubo, A Saito, et al.
The Japanese Journal of Antibiotics|June 15, 1999
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). III Secular changes in susceptibility]M Ogiwara, K Ishibashi, H Yoshida, et al.
The Japanese Journal of Antibiotics|April 30, 1999
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). II. Background of patients]Y Kumamoto, T Tsukamoto, T Hirose, et al.
Oncogene|May 9, 2017
The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activityS Kitajima, A Yoshida, S Kohno, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1997
[Usefulness of 7 day therapy with cefluprenam in the management of respiratory tract infections]K Shimada, M Ohmichi, H Sasaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1997
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal InfectionsJ E Edwards, G P Bodey, R A Bowden, et al.
Pageof 73